Skip to main content

Joseph Capper

Equibles does not estimate personal net worth.

Get an email with a short summary when Anika Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get ANIK alerts

About Joseph Capper

Joseph Capper is recorded as Board Member at Anika Therapeutics, Inc. (ANIK) since May 28, 2024. Anika Therapeutics, Inc. reported in an 8-K filed May 28, 2024 that Joseph Capper was appointed Class II director, effective May 28, 2024. Anika Therapeutics, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Anika Therapeutics, Inc. includes Cheryl Blanchard (CEO and Board Member), Stephen (Steve) Griffin (CEO and Board Member), Stephen D. Griffin (CEO, CFO and Board Member) and 7 others.

“and (ii) Mr. Capper to the Board as a Class II director, with a term expiring at the Company's 2025 annual meeting of stockholders.”
Anika Therapeutics, Inc. Form 8-K, filed May 28, 2024 · Read the filing

Affiliation history

Company network

Current role

Drug Manufacturers - Specialty & Generic · Healthcare

Board Member

2024-05-28–present

Leadership on record at Anika Therapeutics, Inc.

Recent activity